AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates
AnaptysBio (ANAB) delivered earnings and revenue surprises of +78.53% and +28.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?